• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, October 4, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

3D thymic-like hydrogels for T-cell differentiation

by
June 25, 2024
in Chemistry
Reading Time: 4 mins read
0
GEN Biotechnology
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

New Rochelle, NY, June 24, 2024—A new study published in the current issue of the peer-reviewed journal GEN Biotechnology describes the establishment of the first hydrogel-based platform for producing T-cells from hematopoietic stem and progenitor cells. Researchers engineered biomaterials integrated with key thymic components to direct T-cell development, producing functional T-cells with the capability for cytokine production. Click here to read the article now.

Peter Zandstra, from the University of British Columbia, and coauthors of this study state that combining these 3D-engineered hydrogels with cell-based gene therapy could enhance CAR T-cell potency in cancer treatments.

Also featured in the latest issue of GEN Biotechnology is the article titled “Reducing Excessive Fat Accumulation Using Deoxycholate-Based Composite Microparticles.” Solubilized deoxycholic acid has been FDA-approved and used commercially for local fat reduction; however, injection site reactions have limited its success in the clinic. Lola Eniola-Adefeso, from the University of Michigan, and colleagues, reported that optimizing the dosage of deoxycholate-based composite microparticles can significantly reduce fat in a mouse model without causing any visible injection site reactions. The authors also demonstrate the scalability of the particle treatment by modulating the number of injection sites to achieve a well-tolerated, significant fat reduction in a larger rodent model.

In the Perspective article titled “Neural Network Potentials for Advanced Small-Molecule Drug Discovery and Design,” Simon Barnett, from Dimension, describes the merger of key computational technologies such as molecular mechanics force fields and machine learning, in the form of neural network potentials, as a new frontier for rapid, accurate and generalizable small-molecule drug discovery.

Advances in spatially resolved and high-throughput molecular imaging methods, such as multiplexed immunofluorescence and spatial transcriptomics, have given rise to large and complex datasets, leading to the development of innovative machine learning (ML) tools to disentangle signal from noise in complex systems. A Mini-Review by Reza Abassi-Asl, from the University of California, San Francisco, and coauthors, highlights spatial transcriptomics analysis goals addressable by ML. The authors also describe major data science concepts to support researchers in choosing the appropriate tool for their biological question.

About the Journal
GEN Biotechnology is the premier peer-reviewed journal from Mary Ann Liebert, Inc. and Genetic Engineering & Biotechnology News (GEN) delivering exceptional research breakthroughs, news, and analysis directly impacting biotech. Published bimonthly in print and online with flexible open access options, the Journal provides a dynamic forum aimed at unifying both traditional academic audiences and executives and researchers from across the industry.

About the Publisher
Mary Ann Liebert, Inc. is a global media company dedicated to creating, curating, and delivering impactful peer-reviewed research and authoritative content services to advance the fields of biotechnology and the life sciences, specialized clinical medicine, and public health and policy. For complete information, please visit the Mary Ann Liebert, Inc. website.

GEN Biotechnology

Credit: Mary Ann Liebert, Inc.

New Rochelle, NY, June 24, 2024—A new study published in the current issue of the peer-reviewed journal GEN Biotechnology describes the establishment of the first hydrogel-based platform for producing T-cells from hematopoietic stem and progenitor cells. Researchers engineered biomaterials integrated with key thymic components to direct T-cell development, producing functional T-cells with the capability for cytokine production. Click here to read the article now.

Peter Zandstra, from the University of British Columbia, and coauthors of this study state that combining these 3D-engineered hydrogels with cell-based gene therapy could enhance CAR T-cell potency in cancer treatments.

Also featured in the latest issue of GEN Biotechnology is the article titled “Reducing Excessive Fat Accumulation Using Deoxycholate-Based Composite Microparticles.” Solubilized deoxycholic acid has been FDA-approved and used commercially for local fat reduction; however, injection site reactions have limited its success in the clinic. Lola Eniola-Adefeso, from the University of Michigan, and colleagues, reported that optimizing the dosage of deoxycholate-based composite microparticles can significantly reduce fat in a mouse model without causing any visible injection site reactions. The authors also demonstrate the scalability of the particle treatment by modulating the number of injection sites to achieve a well-tolerated, significant fat reduction in a larger rodent model.

In the Perspective article titled “Neural Network Potentials for Advanced Small-Molecule Drug Discovery and Design,” Simon Barnett, from Dimension, describes the merger of key computational technologies such as molecular mechanics force fields and machine learning, in the form of neural network potentials, as a new frontier for rapid, accurate and generalizable small-molecule drug discovery.

Advances in spatially resolved and high-throughput molecular imaging methods, such as multiplexed immunofluorescence and spatial transcriptomics, have given rise to large and complex datasets, leading to the development of innovative machine learning (ML) tools to disentangle signal from noise in complex systems. A Mini-Review by Reza Abassi-Asl, from the University of California, San Francisco, and coauthors, highlights spatial transcriptomics analysis goals addressable by ML. The authors also describe major data science concepts to support researchers in choosing the appropriate tool for their biological question.

About the Journal
GEN Biotechnology is the premier peer-reviewed journal from Mary Ann Liebert, Inc. and Genetic Engineering & Biotechnology News (GEN) delivering exceptional research breakthroughs, news, and analysis directly impacting biotech. Published bimonthly in print and online with flexible open access options, the Journal provides a dynamic forum aimed at unifying both traditional academic audiences and executives and researchers from across the industry.

About the Publisher
Mary Ann Liebert, Inc. is a global media company dedicated to creating, curating, and delivering impactful peer-reviewed research and authoritative content services to advance the fields of biotechnology and the life sciences, specialized clinical medicine, and public health and policy. For complete information, please visit the Mary Ann Liebert, Inc. website.



Journal

GEN Biotechnology

DOI

10.1089/genbio.2024.0010

Method of Research

Experimental study

Subject of Research

People

Article Title

T-Cell Differentiation from Hematopoietic Progenitor Cells Using 3D Thymic-like Hydrogels

Article Publication Date

24-Jun-2024

Share12Tweet8Share2ShareShareShare2

Related Posts

Building Larger Hydrocarbons for Optical Cycling

Building Larger Hydrocarbons for Optical Cycling

October 4, 2025
blank

Scientists Discover How Enzymes “Dance” During Their Work—and Why It Matters

October 4, 2025

Electron Donor–Acceptor Complexes Enable Asymmetric Photocatalysis

October 4, 2025

AI Advances Enhance Sustainable Recycling of Livestock Waste

October 3, 2025

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    93 shares
    Share 37 Tweet 23
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    90 shares
    Share 36 Tweet 23
  • Physicists Develop Visible Time Crystal for the First Time

    75 shares
    Share 30 Tweet 19
  • New Insights Suggest ALS May Be an Autoimmune Disease

    69 shares
    Share 28 Tweet 17

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

HIRAID Framework Enhances Nurse and Patient Outcomes

tRF-34-86J8WPMN1E8Y2Q Fuels Gastric Cancer Progression

Discovering Wuwei Xiaodu Decoction’s Anti-Inflammatory Mechanisms

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 62 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.